These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
420 related items for PubMed ID: 22329977
1. Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit. Demma LJ, Paciullo CA, Levy JH. J Thorac Cardiovasc Surg; 2012 May; 143(5):1213-8. PubMed ID: 22329977 [Abstract] [Full Text] [Related]
2. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients. Demma LJ, Winkler AM, Levy JH. Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317 [Abstract] [Full Text] [Related]
3. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery. Abdillah JN, Hu Q, Chen X, Chen X, Zhou W, Luo W, Huang L. Thorac Cardiovasc Surg; 2019 Jan; 67(1):21-27. PubMed ID: 29605959 [Abstract] [Full Text] [Related]
7. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study. Boyce SW, Bandyk DF, Bartholomew JR, Frame JN, Rice L. Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512 [Abstract] [Full Text] [Related]
8. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG, Argatroban-915 Investigators. Arch Intern Med; 2011 Jan; 163(15):1849-56. PubMed ID: 12912723 [Abstract] [Full Text] [Related]
9. Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital. Kodityal S, Nguyen PH, Kodityal A, Sherer J, Hursting MJ, Rice L. J Intensive Care Med; 2006 Jan; 21(2):86-92. PubMed ID: 16537750 [Abstract] [Full Text] [Related]
10. Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices. Samuels LE, Kohout J, Casanova-Ghosh E, Hagan K, Garwood P, Ferdinand F, Goldman SM. Ann Thorac Surg; 2008 May; 85(5):1651-5. PubMed ID: 18442558 [Abstract] [Full Text] [Related]
11. Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients. Smythe MA, Koerber JM, Forsyth LL, Priziola JL, Balasubramaniam M, Mattson JC. Pharmacotherapy; 2009 Sep; 29(9):1073-81. PubMed ID: 19698012 [Abstract] [Full Text] [Related]
12. Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia. Walenga JM, Ahmad S, Hoppensteadt D, Iqbal O, Hursting MJ, Lewis BE. Thromb Res; 2002 Mar 01; 105(5):401-5. PubMed ID: 12062541 [Abstract] [Full Text] [Related]
13. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study. Hursting MJ, Verme-Gibboney CN. J Cardiovasc Pharmacol; 2008 Dec 01; 52(6):561-6. PubMed ID: 19057393 [Abstract] [Full Text] [Related]